A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2001
11/06/2001	US6312686 Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation
11/06/2001	US6312682 Retroviral vectors
11/06/2001	US6312665 Aerosol formulations for buccal and pulmonary application
11/06/2001	US6312663 Prediction of diabetes impaired wound healing by urinary nitrate assay
11/06/2001	US6312662 Prodrugs phosphorus-containing compounds
11/06/2001	CA2218724C Metabolites of ginseng saponins by human intestinal bacteria and its preparation for an anticancer
11/06/2001	CA2193178C Matrix metalloprotease inhibitors
11/06/2001	CA1341317C Water/paraffinic hydrocarbons emulsion enhanced with lecithin extracts and process for making same
11/06/2001	CA1341315C Targeted forms of methyltrithio antitumor agents
11/06/2001	CA1341314C Derivatives of benzimidazole, benzothiazole and benzoxazole
11/03/2001	CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles
11/02/2001	CA2314494A1 Anionic polymers as species specific antibacterial agents
11/01/2001	WO2001081622A2 Diagnosis of diseases associated with dna repair
11/01/2001	WO2001081599A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081577A2 Dna encoding the prost 03 polypeptide
11/01/2001	WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant
11/01/2001	WO2001081567A2 Method for producing genomic libraries and genomic libraries produced therewith
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081360A1 Novel, photo-labile cumarinylmethyl esters of cyclic nucleotides, method for the production and use thereof
11/01/2001	WO2001081358A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
11/01/2001	WO2001081350A1 Oxazolidinone derivatives with antibiotic activity
11/01/2001	WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
11/01/2001	WO2001081347A2 Diazabicyclic central nervous system active agents
11/01/2001	WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001	WO2001081344A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
11/01/2001	WO2001081343A2 Compounds for treating fibromyalgia and chronic fatigue syndrome
11/01/2001	WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001	WO2001081341A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
11/01/2001	WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	WO2001081339A1 Compositions for treating or preventing malaria and method of treating malaria
11/01/2001	WO2001081337A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081334A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands
11/01/2001	WO2001081333A2 Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
11/01/2001	WO2001081332A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
11/01/2001	WO2001081328A2 Thiazolidinedione analogues and their use for the treatment of diabetes
11/01/2001	WO2001081326A1 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholine receptors activators
11/01/2001	WO2001081325A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
11/01/2001	WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/01/2001	WO2001081319A2 Ultrashort acting hypnotic barbiturates
11/01/2001	WO2001081318A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
11/01/2001	WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	WO2001081314A1 Naphthamidine urokinase inhibitors
11/01/2001	WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
11/01/2001	WO2001081310A1 1-aroyl-piperidinyl benzamidines
11/01/2001	WO2001081309A2 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
11/01/2001	WO2001081308A2 Aminopiperidines for use as glyt-1 inhibitors
11/01/2001	WO2001081307A2 Triaryl cation antibiotics from environmental dna
11/01/2001	WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081303A1 Pyrrolidine and piperidine derivatives and their use for the treament of neurodegenerative disorders
11/01/2001	WO2001081298A2 Cyclic carboxylic acids as integrin antagonists
11/01/2001	WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001	WO2001081288A1 Hydroxyphenstatin and the prodrugs thereof
11/01/2001	WO2001081182A2 Improved method and apparatus for generating an aerosol
11/01/2001	WO2001080945A1 Method for transdermal administration of ascorbic acid
11/01/2001	WO2001080937A1 Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/01/2001	WO2001080896A2 Flavopiridol drug combinations and methods with reduced side effects
11/01/2001	WO2001080895A2 Methods and compositions for the treatment of cardiac indications
11/01/2001	WO2001080894A2 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
11/01/2001	WO2001080893A1 Medicinal compositions promoting bowel movement
11/01/2001	WO2001080892A1 Preventives for influenza
11/01/2001	WO2001080890A2 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
11/01/2001	WO2001080884A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
11/01/2001	WO2001080875A1 A memory enhancing protein
11/01/2001	WO2001080873A2 Thrombopoietin receptor modulating peptide
11/01/2001	WO2001080869A1 Minari extract for preventing the induction and metastasis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks
11/01/2001	WO2001080868A1 Novel medicines based on sesquiterpene mixtures
11/01/2001	WO2001080867A1 Method for improving the quality of sperm for artificial insemination of animals
11/01/2001	WO2001080863A1 Bifunctional antibiotics
11/01/2001	WO2001080862A1 Use of mmp inhibitors in filtering blebs and ischemia
11/01/2001	WO2001080861A1 Infertility or increasing fertility
11/01/2001	WO2001080860A2 Daily treatment for erectile dysfunction using a pde5 inhibitor
11/01/2001	WO2001080858A1 Stable liquid preparation
11/01/2001	WO2001080857A1 Zolpidem hemitartrate
11/01/2001	WO2001080856A2 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
11/01/2001	WO2001080855A1 Telomerase inhibitors and methods of their use
11/01/2001	WO2001080853A1 A combination of pinitol and creatine to enhance uptake and retention of creatine
11/01/2001	WO2001080852A1 Compositions and therapies for hyperlipidaemia-associated disorders
11/01/2001	WO2001080851A1 Method of treating, preventing or inhibiting central nervous system injuries and diseases
11/01/2001	WO2001080850A1 Urea-containing gel preparation
11/01/2001	WO2001080849A1 Method of treating cancer
11/01/2001	WO2001080848A1 Compositions for inhibiting the proliferation of human immunodeficiency virus and method of inhibiting the proliferation of this virus
11/01/2001	WO2001080847A2 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use
11/01/2001	WO2001080845A2 (2-aminoethyl) oxime derivatives for the treatment of depression
11/01/2001	WO2001080844A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
11/01/2001	WO2001080843A2 Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
11/01/2001	WO2001080842A2 Compositions comprising a methylnogarol in combination with an antiproliferative agent
11/01/2001	WO2001080841A2 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
11/01/2001	WO2001080840A2 Cytotoxic agents comprising single-stranded and/or looped dna
11/01/2001	WO2001080839A2 Use of naphthindazole-4,9-quinones as antiparasitic agents
11/01/2001	WO2001080838A2 Use of n2-substituted benz[f]indazole-4,9-quinones as antiparasitic agents
11/01/2001	WO2001080834A1 Composition
11/01/2001	WO2001080832A2 Administration of a thiol-based chemoprotectant compound
11/01/2001	WO2001080830A2 Pharmacotherapeutic process and composition for central nervous system disorders
11/01/2001	WO2001080829A2 Taste masking coating composition
11/01/2001	WO2001080828A2 Improved water-insoluble drug particle process
11/01/2001	WO2001080825A2 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof

1 ... 5976 5977 5978 5979 5980 5981 5982 5983 5984 5985 5986 5987 5988 5989 5990 5991 5992 5993 5994 5995 5996 ... 7860